Mandate

Vinge advises Symphony Technology Group in connection with the public offer for IBS

May 18, 2011

Vinge advises Symphony Technology Group in connection with the public offer for IBS AB, listed on NASDAQ OMX First North. Symphony Technology Group offers SEK 1.75 in cash per share in IBS, regardless of share class, and the board of directors of IBS has unanimously recommended the shareholders to accept the offer. Shareholders representing approximately 75.5 percent of the shares and 81.4 percent of the votes have irrevocably undertaken to accept the offer.

Vinge’s team consists of partner in charge Pontus Enquist as well as Emil Hedberg. In addition, Fabian Ekeblad has advised on banking and finance issues, and Johan Mattsson, Maria Eierborg, Moa Bergsten, Mikael Satama Granberg, Per Westman and Anders Frick, among other, have participated in the due diligence carried out on IBS.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025